Depreciation of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Intra-Cellular Therapies, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Depreciation for the quarter ending 31 Mar 2024 was $132,000, a 1.5% decline year-over-year.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2024 was $508,000, a 3.8% decline from 2023.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2023 was $528,000, a 20% decline from 2022.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2022 was $656,000, a 23% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $508,000 -$20,000 -3.8% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $528,000 -$128,000 -20% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $656,000 +$123,000 +23% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $533,000 +$5,000 +0.95% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $528,000 +$50,879 +11% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $477,121 +$108,448 +29% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $368,673 +$154,801 +72% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $213,872 +$17,000 +8.6% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $196,872 +$57,246 +41% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $139,626 +$114,145 +448% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $25,481 +$2,232 +9.6% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $23,249 -$24,498 -51% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $47,747 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY

Intra-Cellular Therapies, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $132,000 -$2,000 -1.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q1 2023 $134,000 -$37,000 -22% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $577,000 $171,000 +$44,000 +35% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $533,000 $146,474 +$20,620 +16% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $512,380 $133,945 +$12,901 +11% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $499,479 $125,581 -$6,719 -5.1% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $506,198 $127,000 -$21,802 -15% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $528,000 $125,854 -$15,806 -11% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $543,806 $121,044 -$8,008 -6.2% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $551,814 $132,300 +$27,244 +26% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $524,570 $148,802 +$47,449 +47% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $477,121 $141,660 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $129,052 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $105,056 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $101,353 +$18,855 +23% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $82,498 +$32,069 +64% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $50,429 +$2,462 +5.1% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $47,967 +$32,727 +215% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $34,404 $15,240 +$8,923 +141% 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2016 2016 Q1
Q4 2014 $25,481 $6,325 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $6,409 +$1,680 +36% 01 Jul 2014 30 Sep 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 $6,430 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $6,317 +$118 +1.9% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q3 2013 $4,729 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q1 2013 $6,199 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.